Physician profile
David W Ranson
NPI 1306944335
$2,955.37
in general payments reported to CMS, 2019-2025
9 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $98.13 · 2021: $83.72 · 2022: $395 · 2023: $796 · 2024: $870 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,181.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,781.75 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic, INC. | $569.04 | 2021-2024 | Closurefast, Venaseal, Closurerfg |
| Medtronic Vascular, INC. | $220.20 | 2019-2020 | |
| Boston Scientific Corporation | $179.59 | 2022-2024 | Varithena Administration Pack |
| Smith+Nephew, INC. | $140.76 | 2020-2024 | Collagenase Santyl |
| Myriad Genetic Laboratories, INC. | $23.82 | 2023 | Myrisk |
| Novartis Pharmaceuticals Corporation | $19.94 | 2020 | |
| Biocompatibles, INC. | $16.69 | 2019 | |
| Advanced Oxygen Therapy INC. | $3.58 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ranson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.